Literature DB >> 9121811

Rapid recovery from capsaicin desensitization during recurrent stimulation.

B G Green1.   

Abstract

Topical desensitization of the tongue was assessed during multiple bouts of exposure to capsaicin. In the first experiment subjects rated perceived irritation as 30 capsaicin stimuli (33 microM) were applied to the tongue tip in three blocks of 10, with 15 min breaks between blocks. Significant desensitization was measured at the beginning of the second and third blocks within each session. However, as stimulation continued within those blocks sensations of irritation grew toward undesensitized levels ('stimulus-induced recovery' (SIR)). Desensitization did not extend across days. The second experiment employed a 10-fold higher concentration of capsaicin (330 microM) to determine if SIR was limited to low levels of desensitization. SIR occurred as before within sessions, and the higher concentration produced desensitization across days that also exhibited recovery during the first block of stimuli on days 2 and 3. The third experiment included piperine, zingerone and citric acid as stimuli to determine if SIR was specific to capsaicin. Piperine produced SIR under conditions of both self- and cross-desensitization with capsaicin, whereas recovery failed to materialize with zingerone. Citric acid was not significantly cross-desensitized by capsaicin, so recovery could not be measured. Overall the results demonstrate that desensitization of the tongue produced by either capsaicin or piperine can be temporarily reversed if stimulation with either chemical is resumed for only a few minutes. The implications these findings may have for hypotheses about the mechanisms of capsaicin desensitization and sensitization as well as for clinical applications of capsaicin as a topical analgesic are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9121811     DOI: 10.1016/s0304-3959(96)03211-3

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

1.  Differential bitterness in capsaicin, piperine, and ethanol associates with polymorphisms in multiple bitter taste receptor genes.

Authors:  Alissa A Nolden; John E McGeary; John E Hayes
Journal:  Physiol Behav       Date:  2016-01-16

2.  Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1).

Authors:  Fergal N McNamara; Andrew Randall; Martin J Gunthorpe
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

3.  Influence of topical application of capsaicin, menthol and local anesthetics on intraoral somatosensory sensitivity in healthy subjects: temporal and spatial aspects.

Authors:  Takuya Naganawa; Lene Baad-Hansen; Tomohiro Ando; Peter Svensson
Journal:  Exp Brain Res       Date:  2015-01-18       Impact factor: 1.972

4.  Gastroprotection induced by capsaicin in healthy human subjects.

Authors:  Gyula Mózsik; János Szolcsányi; István Rácz
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

5.  Behavioral measures of risk tasking, sensation seeking and sensitivity to reward may reflect different motivations for spicy food liking and consumption.

Authors:  Nadia K Byrnes; John E Hayes
Journal:  Appetite       Date:  2016-04-29       Impact factor: 3.868

6.  Somatosensory profiling of intra-oral capsaicin and menthol in healthy subjects.

Authors:  Shengyi Lu; Lene Baad-Hansen; Thomas List; Zhenting Zhang; Peter Svensson
Journal:  Eur J Oral Sci       Date:  2013-02       Impact factor: 2.612

7.  The pungent substances piperine, capsaicin, 6-gingerol and polygodial inhibit the human two-pore domain potassium channels TASK-1, TASK-3 and TRESK.

Authors:  Leopoldo R Beltrán; Corinna Dawid; Madeline Beltrán; Guenter Gisselmann; Katharina Degenhardt; Klaus Mathie; Thomas Hofmann; Hanns Hatt
Journal:  Front Pharmacol       Date:  2013-11-18       Impact factor: 5.810

Review 8.  Integrating TRPV1 Receptor Function with Capsaicin Psychophysics.

Authors:  Gregory Smutzer; Roni K Devassy
Journal:  Adv Pharmacol Sci       Date:  2016-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.